Marina M. S.
- Country
- Spain
- Department
- Neurology Department
Research Overview
Data & Insights
Has run more than one trial at 0 of 33 partner sites.
Specializations
Neurology and Neurodegenerative Disorders
Investigations target central nervous system conditions such as Multiple Sclerosis, Parkinson's disease, and idiopathic generalized epilepsy, with emphasis on disease‑modifying approaches.
- Multiple Sclerosis
- Parkinson's disease
- Idiopathic generalized epilepsy
- Neurofibromatosis Type 1
- Primary progressive multiple sclerosis
Efforts include biomarker identification and therapeutic optimization for progressive neuro‑disorders.
Autoimmune and Inflammatory Skin Diseases
Research addresses cutaneous immune-mediated conditions, including cutaneous lupus erythematosus, psoriasis, and atopic dermatitis, focusing on targeted immunomodulation.
- Cutaneous lupus erythematosus
- Psoriasis
- Atopic dermatitis
- Bullous pemphigoid
- Vitiligo
Studies aim to improve skin integrity and reduce systemic inflammatory burden.
Hematologic Malignancies and Myeloproliferative Disorders
Clinical work encompasses blood‑cancer entities such as acute myeloid leukemia, chronic lymphocytic leukemia, and myelofibrosis, with a view toward novel therapeutic regimens.
- Acute myeloid leukemia
- Chronic lymphocytic leukemia
- Myelofibrosis
- Multiple myeloma
- Acute lymphoblastic leukemia
Efforts prioritize precision medicine and resistance mitigation.
Solid Tumor Oncology
Investigations span major solid cancers, including non‑small cell lung cancer, ER‑positive/HER2‑negative breast cancer, and prostate carcinoma, emphasizing targeted and immunotherapeutic strategies.
- Non‑small cell lung cancer
- ER‑positive/HER2‑negative breast cancer
- Prostate carcinoma
- Gastric adenocarcinoma
- Melanoma
Research focuses on molecular profiling and combination therapies to enhance survival outcomes.
Cardiovascular and Metabolic Disorders
Clinical focus includes vascular and metabolic conditions such as acute ischemic stroke, atrial fibrillation, and type 2 diabetes mellitus, seeking to reduce morbidity through innovative interventions.
- Acute ischemic stroke
- Atrial fibrillation
- Heart failure
- Atherosclerotic cardiovascular disease
- Type 2 diabetes mellitus
Projects aim to integrate cardiovascular risk reduction with metabolic health optimization.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.